PEOPLE - Changes at Calypte Biomedical (US):
This article was originally published in Clinica
HIV-1 antibody test producer Calypte Biomedical (Alameda, California) has appointed Richard George as president and CEO and Richard Van Maanen as vice-president of operations. Dr George has 35 years of experience with the Centers for Disease Control and Prevention (CDC) and Mr Van Maanen has been involved with HIV diagnostics industry for 19 years. Calypte Biomedical has also announced the departure of Jay Oyakawa, who has resigned from his position as president and COO.